ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,304.72
0.70%
US Tech 100
18,318.00
0.95%
다우존스 지수
39,069.59
0.01%
Bitcoin
68,554.41
0.06%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Cesca Therapeutics Inc (KOOL)

  7. Cesca Therapeutics Inc (KOOL) 뉴스

KOOL

Cesca Therapeutics (KOOL)

Cesca Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:KOOL
일자시간출처헤드라인심볼기업
2019/10/3119:30PR Newswire (US)Cesca Therapeutics To Change Name And Ticker Symbol To Reflect New Strategic FocusNASDAQ:KOOLCesca Therapeutics Inc
2019/10/2421:30PR Newswire (US)Cesca Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth ConferenceNASDAQ:KOOLCesca Therapeutics Inc
2019/10/2223:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KOOLCesca Therapeutics Inc
2019/10/2223:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KOOLCesca Therapeutics Inc
2019/10/2219:30PR Newswire (US)Cesca Therapeutics Forms Joint Venture with Healthbanks Biotech (USA) to Provide Immune Cell Banking and Cell Processing Serv...NASDAQ:KOOLCesca Therapeutics Inc
2019/10/1421:30PR Newswire (US)Cesca Therapeutics To Present At The 2019 Bio Investor ForumNASDAQ:KOOLCesca Therapeutics Inc
2019/10/0221:30PR Newswire (US)Cesca Therapeutics Announces Receipt Of $2 Million Upfront Distribution FeeNASDAQ:KOOLCesca Therapeutics Inc
2019/09/2523:25PR Newswire (US)ThermoGenesis Reports Performance Evaluations of X-Series® Cell Processing DevicesNASDAQ:KOOLCesca Therapeutics Inc
2019/09/2503:35Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:KOOLCesca Therapeutics Inc
2019/09/1907:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KOOLCesca Therapeutics Inc
2019/09/1907:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KOOLCesca Therapeutics Inc
2019/09/1907:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KOOLCesca Therapeutics Inc
2019/09/1306:08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:KOOLCesca Therapeutics Inc
2019/09/1119:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KOOLCesca Therapeutics Inc
2019/09/0921:30PR Newswire (US)Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® ProductsNASDAQ:KOOLCesca Therapeutics Inc
2019/09/0706:26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KOOLCesca Therapeutics Inc
2019/09/0321:30PR Newswire (US)Cesca Therapeutics To Present At The H.C. Wainwright 21st Annual Global Investment ConferenceNASDAQ:KOOLCesca Therapeutics Inc
2019/08/1419:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KOOLCesca Therapeutics Inc
2019/08/1405:35Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KOOLCesca Therapeutics Inc
2019/08/1405:05PR Newswire (US)Cesca Therapeutics Announces Improved Second Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:KOOLCesca Therapeutics Inc
2019/08/0621:30PR Newswire (US)Cesca Therapeutics To Announce Financial Results For The Second Quarter Ended June 30, 2019 And Host A Conference Call On Aug...NASDAQ:KOOLCesca Therapeutics Inc
2019/07/3006:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KOOLCesca Therapeutics Inc
2019/07/3001:47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KOOLCesca Therapeutics Inc
2019/07/2321:30PR Newswire (US)America's Largest Cord Blood Bank, CBR®, Upgrading to ThermoGenesis' AXP® II SystemNASDAQ:KOOLCesca Therapeutics Inc
2019/07/1205:35Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:KOOLCesca Therapeutics Inc
2019/06/2703:52Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KOOLCesca Therapeutics Inc
2019/06/2621:30PR Newswire (US)Cesca Therapeutics Regains Nasdaq Listing ComplianceNASDAQ:KOOLCesca Therapeutics Inc
2019/06/2521:30PR Newswire (US)Cordlife to Use the ThermoGenesis AXP® II System for Rapid Processing of Cord Blood Units in IndiaNASDAQ:KOOLCesca Therapeutics Inc
2019/06/1821:30PR Newswire (US)ThermoGenesis Receives Health Canada Approval of its Next-Generation AXP® II System for Cord Blood ProcessingNASDAQ:KOOLCesca Therapeutics Inc
2019/06/0521:30PR Newswire (US)ThermoGenesis to Participate in The Orthobiologic Institute's 10th Annual PRP & Regenerative Medicine SymposiumNASDAQ:KOOLCesca Therapeutics Inc
 검색 관련기사 보기:NASDAQ:KOOL

최근 히스토리

NYSE
NETC.WS
Nabors Energy Transition
COIN
TOSBTC
ThingsOpreatingSystem
GATE
HSRETH
Hcash
BITMOT
785372
Bnp Tf 2,75% Ge26 Sub Ti...
LSE
14NW
Cs Ag 21
BIT
UB9572
Unicredit Bank
COIN
WHITEETH
Whiteheart Token
LSE
37QP
York Water 51
COIN
CRDSBTC
USOTC
ACTX
Advanced Container Techn... (CE)
EU
E182S
E182S
LSE
1090
ASX
ANZBOR
NASDAQ
LAAUX
Western Asset Core Plus ...
COIN
TMTGUST
EU
INDS2
Etfs DES2 VLI
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유